DOTS Technology Corp was co-founded by an entrepreneur whose daughter has a food allergy and a Harvard molecular biologist. Founded with a shared vision to make people’s lives better, Renuka Babu and Dr. Adi Gilboa-Geffen invented a novel and highly specific way to detect proteins. This platform will help improve the quality of life for millions of people. Renuka Babu, MBA, CEO & Co-Founder Renuka Babu is the CEO & Co-Founder of DOTS. Babu has held leadership positions both in biotech and financial start-ups including the RiskMetrics Group (now MSCI), ArQule (ARQL), and MEND (delivery technologies for diseases of poverty). She also served as Executive Director of New Ventures at Boston University where she focused on commercializing intellectual property. Babu obtained her BA from Bryn Mawr College and her MBA from the University of Chicago. Dr. Adi Gilboa-Geffen, Ph.D., Co-Founder & CSO Harvard molecular biologist specializing in immunology, Dr. Gilboa-Geffen has extensive experience in Oligonucleotide therapeutic research. Her work has focused on therapeutic treatment of triple negative breast cancer, and she successfully led therapeutic constructs from IBD and Alzheimer’s disease. She has a PhD with Honors from the Hebrew University in Jerusalem, and did her post-doctoral training at Bonn University and Harvard Medical School. 
